M&A Deal Summary

Flagship Biosciences Acquires Interpace Pharma Solutions

On August 31, 2022, Flagship Biosciences acquired life science company Interpace Pharma Solutions from Interpace

Acquisition Highlights
  • This is Flagship Biosciences’ 1st transaction in the Life Science sector.
  • This is Flagship Biosciences’ 1st transaction in the United States.
  • This is Flagship Biosciences’ 1st transaction in North Carolina.

M&A Deal Summary
Date 2022-08-31
Target Interpace Pharma Solutions
Sector Life Science
Buyer(s) Flagship Biosciences
Sellers(s) Interpace
Deal Type Divestiture

Target

Interpace Pharma Solutions

Research Triangle Park, North Carolina, United States
Interpace Pharma Solutions provides complex molecular analysis services supporting clinical trials and diagnostic development. These services include genomic profiling, biomarker solutions, project and data management, bioinformatics analysis, and biorepository services. Interpace Pharma Solutions is based in Research Triangle Park, North Carolina.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Flagship Biosciences

Broomfield, Colorado, United States
Category Company
Founded 2009
Sector Information Technology
DESCRIPTION

Flagship Biosciences is a technology-driven tissue analysis services company delivering accurate and informative data available. Flagship Biosciences' services and technology dramatically improve the data and interpretation from traditional pathology methods, eliminating variability associated with typical tissue assessments, and bringing new insights to tissue analysis results. It provides expert scientific consultation for every client. The company's team interprets results, contextualizes tissue biology, and identifies the best course for success. Flagship Biosciences was formed in 2009 and is based in Broomfield, Colorado.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (North Carolina) 1 of 1
Country (United States) 1 of 1
Year (2022) 1 of 1

Seller(S) 1

SELLER

Interpace

Parsippany, New Jersey, United States
Category Company
Founded 1986
Sector Life Science
Employees108
Revenue 40M USD (2023)
DESCRIPTION

Interpace engages in enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Interpace Biosciences was founded in 1986 and is based in Parsippany, New Jersey.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 1 of 1
Type (Divestiture) 2 of 2
State (North Carolina) 1 of 1
Country (United States) 2 of 2
Year (2022) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-03-17 Interpace Biosciences - CLIA Lab

New Haven, Connecticut, United States

Interpace Biosciences' CLIA Lab (Clinical Laboratory Improvement Amendments) certified laboratory providing diagnostic services in New Haven, CT.

Sell -
Mergr

Product

Company

Legal